Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi

被引:0
|
作者
Vijay B Bansode
Simon AA Travers
Amelia C Crampin
Bagrey Ngwira
Neil French
Judith R Glynn
Grace P McCormack
机构
[1] Ryan Institute,Molecular Evolution and Systematics Laboratory, Zoology
[2] School of Natural Sciences,Department of Epidemiology and Population Health
[3] National University of Ireland,undefined
[4] South African National Bioinformatics Institute,undefined
[5] University of the Western Cape,undefined
[6] Karonga Prevention Study,undefined
[7] London School of Hygiene and Tropical Medicine,undefined
来源
AIDS Research and Therapy | / 8卷
关键词
HIV-1; drug resistance; subtype C; ART; Malawi; Reverse transcriptase;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Reverse transcriptase drug resistance mutations in HIV-1 subtype C infected patients on ART in Karonga District, Malawi
    Bansode, Vijay B.
    Travers, Simon A. A.
    Crampin, Amelia C.
    Ngwira, Bagrey
    French, Neil
    Glynn, Judith R.
    McCormack, Grace P.
    AIDS RESEARCH AND THERAPY, 2011, 8
  • [2] Drug resistance mutations in protease gene of HIV-1 subtype C infected patient population
    Misbah M.
    Gupta P.
    Roy G.
    Kumar S.
    Husain M.
    VirusDisease, 2021, 32 (3) : 480 - 491
  • [3] HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance
    Shafer, Robert W.
    Rhee, Soo-Yon
    Pillay, Deenan
    Miller, Veronica
    Sandstrom, Paul
    Schapiro, Jonathan M.
    Kuritzkes, Daniel R.
    Bennett, Diane
    AIDS, 2007, 21 (02) : 215 - 223
  • [4] Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
    Singh, Kamalendra
    Flores, Jacqueline A.
    Kirby, Karen A.
    Neogi, Ujjwal
    Sonnerborg, Anders
    Hachiya, Atsuko
    Das, Kalyan
    Arnold, Eddy
    McArthur, Carole
    Parniak, Michael
    Sarafianos, Stefan G.
    VIRUSES-BASEL, 2014, 6 (09): : 3535 - 3562
  • [5] Comparison of drug resistance mutations and their interpretation in patients infected with non-B HIV-1 variants and matched patients infected with HIV-1 subtype B
    Montes, B
    Vergne, L
    Peeters, M
    Reynes, J
    Delaporte, E
    Segondy, M
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2004, 35 (04) : 329 - 336
  • [6] Structural basis for the resilience of efavirenz (DMP-266) to drug resistance mutations in HIV-1 reverse transcriptase
    Ren, J
    Milton, J
    Weaver, KL
    Short, SA
    Stuart, DI
    Stammers, DK
    STRUCTURE, 2000, 8 (10) : 1089 - 1094
  • [7] Characterization of Nucleoside Reverse Transcriptase Inhibitor-Associated Mutations in the RNase H Region of HIV-1 Subtype C Infected Individuals
    Ngcapu, Sinaye
    Theys, Kristof
    Libin, Pieter
    Marconi, Vincent C.
    Sunpath, Henry
    Ndung'u, Thumbi
    Gordon, Michelle L.
    VIRUSES-BASEL, 2017, 9 (11):
  • [8] Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
    G. N. Nikolenko
    A. T. Kotelkin
    S. F. Oreshkova
    A. A. Ilyichev
    Molecular Biology, 2011, 45 : 93 - 109
  • [9] Mechanisms of HIV-1 drug resistance to nucleoside and nonnucleoside reverse transcriptase inhibitors
    Nikolenko, G. N.
    Kotelkin, A. T.
    Oreshkova, S. F.
    Ilyichev, A. A.
    MOLECULAR BIOLOGY, 2011, 45 (01) : 93 - 109
  • [10] Polymorphism and drug selected mutations of reverse transcriptase gene in 102 HIV-1 infected patients living in China
    Liu, Li
    Lu, Hong Zhou
    Henry, Mireille
    Tamalet, Catherine
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (10) : 1593 - 1599